Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

SELLAS Life Sciences (SLS) Other Operating Expenses (2019 - 2023)

SELLAS Life Sciences (SLS) has disclosed Other Operating Expenses for 8 consecutive years, with $184000.0 as the latest value for Q1 2023.

  • On a quarterly basis, Other Operating Expenses rose 2144.44% to $184000.0 in Q1 2023 year-over-year; TTM through Dec 2023 was $184000.0, a 43.21% decrease, with the full-year FY2022 number at $10.1 million, up 71.19% from a year prior.
  • Other Operating Expenses was $184000.0 for Q1 2023 at SELLAS Life Sciences, up from $124000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $5.7 million in Q4 2021 to a low of -$178000.0 in Q1 2019.
  • A 5-year average of $415466.7 and a median of -$18000.0 in 2019 define the central range for Other Operating Expenses.
  • Peak YoY movement for Other Operating Expenses: tumbled 668.42% in 2021, then skyrocketed 2144.44% in 2023.
  • SELLAS Life Sciences' Other Operating Expenses stood at -$21000.0 in 2019, then surged by 190.48% to $19000.0 in 2020, then soared by 29900.0% to $5.7 million in 2021, then crashed by 97.82% to $124000.0 in 2022, then skyrocketed by 48.39% to $184000.0 in 2023.
  • Per Business Quant, the three most recent readings for SLS's Other Operating Expenses are $184000.0 (Q1 2023), $124000.0 (Q3 2022), and $209000.0 (Q2 2022).